TScan Therapeutics

TScan Therapeutics is a Nasdaq-listed clinical-stage biotechnology company developing T cell receptor (TCR)-engineered T cell therapies for cancer, with a technology adoption partnership with Cellares to evaluate automated manufacturing of its TSC-101 candidate.

Company Facts

• Headquarters: Waltham, United States
• Founded: 2018
• Type: public
• Website: https://www.tscan.com
• Industries: Biopharmaceuticals, Cell Therapy, Oncology